Bioventus Inc.

NASDAQ: BVS · Real-Time Price · USD
7.36
0.02 (0.27%)
At close: Aug 15, 2025, 3:59 PM
7.37
0.14%
After-hours: Aug 15, 2025, 05:36 PM EDT

Bioventus Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 28, 2025 Mar 29, 2025 Dec 31, 2024 Sep 28, 2024 Jun 29, 2024 Mar 30, 2024 Dec 31, 2023 Sep 30, 2023 Jul 1, 2023 Apr 1, 2023 Dec 31, 2022 Oct 1, 2022 Jul 2, 2022 Apr 2, 2022 Dec 31, 2021 Oct 2, 2021 Jul 3, 2021 Apr 3, 2021
Revenue
564.14M 567.7M 573.28M 555.06M 536.89M 522.74M 512.35M 502.76M 510.62M 513.89M 512.12M 516.7M 496.93M 466.41M 430.9M 399.07M 376.09M 324.29M
Cost of Revenue
182.79M 184.8M 185.05M 183.19M 179.72M 180.09M 184.15M 186.68M 188.86M 184.59M 181.04M 172.04M 157.73M 147.56M 128.19M 110.67M 104.29M 88.45M
Gross Profit
381.35M 382.9M 388.23M 371.87M 357.17M 342.65M 328.19M 316.08M 321.77M 329.3M 331.08M 344.66M 339.19M 318.85M 302.71M 288.41M 271.8M 235.84M
Operating Income
35.3M -12.44M -11.98M -18.8M -20.46M 15.66M -81.72M -108.33M -237.58M -247.64M -177.03M -154.75M -28.95M -31.39M 12.06M 21.12M 29.1M 30.25M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.55M 1.55M 1.55M 1.55M 2.88M 2.88M 2.88M 2.88M
Pretax Income
2.3M -47.47M -49.13M -57.76M -61.12M -26.02M -121.11M -162.42M -284.79M -287.21M -206.98M -161.88M -34.48M -36.77M 7.62M 15.38M 26.87M 29.84M
Net Income
-158K -31.61M -33.54M -39.48M -41.96M -21.65M -156.23M -182.06M -283.01M -286.58M -158.7M -127.14M -19.96M -16.84M 19.38M 22.52M 32.04M 30.4M
Selling & General & Admin
320.31M 335.99M 340.89M 332.64M 321.37M 301.43M 303.88M 302.96M 312.09M 326.87M 332.13M 335.58M 326.26M 305.69M 254.25M 235.35M 216M 187.49M
Research & Development
13.24M 14.05M 13.64M 13.65M 12.86M 12.27M 13.45M 16.99M 18.59M 21.56M 24.71M 25.01M 26.55M 25.02M 19.04M 14.83M 12.24M 10M
Other Expenses
6.48M 40.72M 41.09M 36.28M 39.88M 9.78M 89.08M 104.22M 100.63M 100.47M 23.23M 11.01M 15.34M 19.53M 17.35M 17.12M 14.46M 8.1M
Operating Expenses
340.04M 390.76M 395.63M 386.09M 377.63M 326.99M 330.7M 335.39M 470.33M 487.92M 498.31M 499.41M 368.15M 350.24M 290.64M 267.29M 242.7M 205.59M
Interest Expense
33.53M 35.96M 38.79M 40.08M 40.66M 41.32M 40.68M 45.27M 38.76M 30.75M 21.05M 7.14M 4.88M 3.99M 3.99M 5.68M 6.22M 4.54M
Selling & Marketing Expenses
n/a n/a n/a 3.85M 3.85M 3.85M 3.85M 5.2M 5.2M 5.2M 5.2M 3.87M 3.87M 3.87M 3.87M 2.77M 2.77M 2.77M
Cost & Expenses
522.82M 575.56M 580.68M 569.28M 557.35M 507.08M 594.07M 601.28M 738.41M 751.73M 679.35M 671.44M 525.88M 497.8M 418.84M 377.96M 346.99M 294.05M
Income Tax Expense
2.08M -6.29M -5.29M -6.59M -6.58M 1.14M 85K -4.01M -34.13M -33.27M -38.25M -36.14M -7.5M -7.03M -1.97M 1.65M 2.9M 1.08M
Shares Outstanding (Basic)
66.5M 66.01M 65.45M 65.26M 64.06M 63.38M 63.1M 62.82M 62.55M 62.12M 61.93M 61.67M 61.48M 60.48M 45.47M 41.84M 41.81M 41.8M
Shares Outstanding (Diluted)
68.54M 66.01M 65.45M 65.26M 64.06M 63.38M 63.1M 62.82M 62.55M 62.12M 61.93M 61.67M 61.48M 60.48M 54.73M 41.84M 41.81M 41.8M
EPS (Basic)
-0.01 -0.49 -0.52 -0.61 -0.66 -0.35 -2.52 -2.94 -4 -4.05 -2 -1.49 -0.33 -0.32 0.47 0.53 0.71 0.71
EPS (Diluted)
-0.01 -0.49 -0.52 -0.61 -0.66 -0.35 -2.52 -2.94 -4 -4.05 -2 -1.49 -0.33 -0.32 0.47 0.53 0.71 0.71
EBITDA
72M 38.13M 39.22M 31.93M 30.7M 67.98M -23.07M -43.11M -154.86M -167.51M -101.63M -87.17M 15.55M 15.41M 52.72M 56.54M 67.31M 61.91M
EBIT
18.02M -11.51M -10.33M -17.69M -20.46M 15.3M -80.44M -117.17M -246.05M -256.2M -186.33M -155.13M -29.98M -25.49M 17.11M 26.57M 38.59M 33.42M
Depreciation & Amortization
37.98M 49.63M 49.55M 49.62M 51.17M 52.68M 57.37M 68.06M 67.83M 65.61M 61.62M 50.15M 45.08M 40.17M 34.88M 30.04M 28.79M 28.56M